PET Alzheimer’s coverage query renewed
This article was originally published in The Gray Sheet
CMS accepts UCLA's revised request for a national coverage decision after the agency issued a non-coverage determination in April (1"The Gray Sheet" April 21, 2003, p. 4). UCLA now is seeking Medicare coverage of PET scans in patients "with a gradually progressive decline in one or more cognitive domains" and/or "cognitive impairment due to memory loss, who have had a comprehensive physical including neurological testing and who do not suffer from severe dementia." CMS expects to complete the review by Jan. 7...
You may also be interested in...
CMS continues to support research on FDG-PET in the diagnosis of Alzheimer's disease (AD), despite an April 16 non-coverage decision
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.